Results 91 to 100 of about 6,415 (210)

Anidulafungin liposome nanoparticles exhibit antifungal activity against planktonic and biofilm Candida albicans

open access: yes, 2020
Fungal infections can cause significant patient morbidity and mortality. Nanoparticle therapeutics have the potential to improve treatment of these infections.
Luc Langlois   +13 more
core   +1 more source

Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies

open access: yes, 2018
Objectives: We aimed to establish a novel murine intra-abdominal foreign body infection model to study the activity of anidulafungin and tigecycline against dual species Candida albicans/Staphylococcus aureus biofilms.
Rogiers, Ona   +15 more
core   +1 more source

Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology

open access: yes, 2012
Objectives: the aims of the study were to explore the activity of total and free (according to protein binding) maximal concentrations achieved in serum after multiple doses of voriconazole 400/200 mg and anidulafungin 200/100 mg against Aspergillus ...
Alou Cervera, Luis   +7 more
core  

A Comparative Study of the Effects of Intravitreal Anidulafungin, Voriconazole, and Amphotericin B in an Experimental Candida Endophthalmitis Model

open access: yes, 2017
Purpose: To compare the safety and efficacy of intravitreal anidulafungin injection with voriconazole and amphotericin B (Amp B) in an experimental Candida endophthalmitis (CE) model.Methods: Intravitreal 1 x 10(5) CFU/0.1 ml Candida albicans was ...
Uyanık, Muhammet Hamidullah   +7 more
core   +1 more source

Pharmakokinetik von Anidulafungin während kontinuierlicher Hämofiltration

open access: yes, 2010
Anidulafungin, ein Echinocandin-Antimykotikum, welches zur neuesten Substanzklasse von Antimykotika gehört, weist ein breites Wirkspektrum gegen Candida-Infektionen und Aspergillosen auf. Der Arzneistoff wird bei schweren systemischen Mykosen eingesetzt.
Stelzer, Christoph
core  

Anidulafungin-a new therapeutic option for Candida infections in liver transplantation.

open access: yes, 2012
INTRODUCTION: In the last years, the incidence of Candida infections in liver transplant recipients has increased with still higher morbidity and mortality. Anidulafungin, a new echinocandin that does not interfere with cytochrome p450, shows no need for
Bianco, Giuseppe   +7 more
core   +2 more sources

Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit

open access: yes, 2009
Recent studies suggest that differences in antifungal activity among echinocandins may exist. In this study, the activities of three echinocandins (anidulafungin, caspofungin, and micafungin) against Candida parapsilosis isolates from burn unit patients,
Ghannoum, M.A.   +7 more
core   +1 more source

Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia

open access: yes, 2014
BackgroundAlthough echinocandins have high in vitro antifungal efficacy according to prior reports, comparative studies on the clinical cure rates of anidulafungin, caspofungin, and micafungin in systemic candida infections have not yet been reported ...
See, Lai-Chu   +5 more
core   +1 more source

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients

open access: yesClinicoEconomics and Outcomes Research, 2015
S Grau,1 JC Pozo,2 E Romá,2 M Salavert,3 JA Barrueta,4 C Peral,4 I Rodriguez,5 D Rubio-Rodríguez,6 C Rubio-Terrés6 1Hospital del Mar (IMIM), Barcelona, 2Hospital Universitario Reina Sofía, Córdoba, 3Hospital ...
Grau S   +8 more
doaj  

Multicenter Analysis of Anidulafungin Use in Invasive Candida Infections

open access: yes, 2019
Giriş: Tüm dünyada fungal infeksiyonlar önemli bir sorun olup değişen hasta profili ile birlikte sıklığı artmıştır. Özellikle kandida halen en sık karşılaşılan fungal etken olup son yıllarda albikans dışı kandidaların önemi artmıştır.
Kutsoylu, Oya Eren   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy